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Background: Saliva and sweat are modified by cystic fibrosis (CF). In both cases the chloride and sodium ion
concentrations for healthy subjects and CF patients differ, this representing a possible alternative tool for CF
diagnosis. In this context, the aim of this study was to compare the concentrations of these ions in saliva samples
taken from CF patients and healthy subjects.
Methods: A case–control study was carried out at a university CF center, in which the saliva samples were analyzed
on an ABL 835 RadiometerW to determine the ion concentration.
Results: For the CF patients (n = 80) the values for the biochemical parameters of chloride, potassium and sodium
ion concentration were higher (p < 0.009) and the volume and pH of the saliva were lower than in the case of
healthy subjects (p < 0.009). For the healthy subjects group (n = 84) versus CF patients, according to the ROC curve,
the values for sodium were: cutoff: 13.5 mmol/L, sensitivity: 73.4%, specificity: 70.6%; and for chloride: cutoff:
20 mmol/L, sensitivity: 68.1%, specificity: 72.9%.
Conclusions: The chloride and sodium concentrations in the saliva samples were higher for CF patients in
comparison with healthy subjects. Thus, saliva as a tool for CF diagnosis can be considered a new challenge, and a
population study including patients in all age classes needs to be performed, in different countries over the world,
to extend the database to include a broad spectrum of information in order to identify normal ion concentration
ranges for CF patients according to age, genotype and environment.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2614233148750145
Keywords: Saliva, Ion concentration, Cystic fibrosis, Lung disease, CFTRBackground
Cystic fibrosis (CF), the most common genetic disease
in Caucasians, is a hereditary exocrinopathy with a wide
range of clinical and genetic variants [1].
Paul di Sant'Agnese et al. [2] investigated the ionic
composition of sweat in CF patients and found higher
concentrations of chloride, sodium and potassium in
comparison to healthy subjects. To decrease the diffi-
culties associated with obtaining sufficient quantities of
sweat to determine the concentration of electrolytes,* Correspondence: licgoncalves@yahoo.com.br
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distribution, and reproduction in any mediumGibson and Cook [3] proposed using the cholinergic
stimulation technique on a small area of skin via pilo-
carpine iontophoresis. The quantitative analysis of sweat
chloride levels is currently applied as a discriminatory
test for CF diagnosis [4].
The cystic fibrosis transmembrane conductance regu-
lator (CFTR) protein forms a channel which allows
chloride ions to cross the cell membrane of epithelial
cells in both directions depending on the electrochem-
ical gradient, this being important in the production of
airway surface liquid, exocrine pancreatic secretion and
sweat [5].
Sweat in healthy subjects is hypotonic in relation to the
extracellular fluid to ensure an effective heat loss which is
essential to maintaining the proper body temperature. Intral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://www.diagnosticpathology.org/content/8/1/46the sweat gland acini, the primary gland secretion has an
ionic composition similar to that of interstitial fluid. The
primary secretion of sweat glands, when passing through
glandular ducts, loses chloride and sodium ions, which are
absorbed by the CFTR and sodium (ENaC) channel, re-
spectively. The ion absorption without corresponding
water absorption leads to hypotonic sweat [6]. The mech-
anism of saliva production has similarities with that of
sweat production.
Saliva is a secretion which is produced by four glands:
parotid (serous secretion), oral (mucous secretion) and
submandibular and sublingual (serous and mucous se-
cretion). The primary secretion in the acinus of the
glands has an ion concentration similar to those of the
plasma and interstitial fluid. Along the ducts, the ab-
sorption of specific ions and secretion and/or passive
movement in opposite directions reduces the levels of
sodium and chloride ions and increases those of bicar-
bonate and potassium ions.
The involvement of CFTR and ENaC in the ducts of
salivary glands has been demonstrated in homozygous
mice for the F508del mutation [6]. Therefore, it can be
hypothesized that these channels play a role in ion ab-
sorption in salivary gland ducts, similarly to sweat
glands.
Iontophoresis as a stimulus for the production of sweat
presents difficulties associated with: (i) a low amount of
sweat, (ii) equipment availability, (iii) child immobilization
and stress, (iv) obtaining the amount of sweat required to
repeat the test.
Due to the drawbacks related to implementing this
technique, other diagnostic possibilities have been
sought and in this regard the biochemical parameters
in saliva represent a potential tool for CF diagnosis.Table 1 Comparison of volume, pH and biochemical paramet
controls
Parameter CF patients (n=80)
Mean ± SD (95% CI) Median Mean
Calcium* 2.03± 0.99 (0.30 – 4.65) 1.85 2.15 ±
Glucose* 13.02 ± 18.69 (3 – 147) 8 9.25±
Lactate* 0.91 ± 0,89 (0.2 – 5.6) 0.7 0.81±
Chloride* 27.82 ± 13.47 (12 – 89) 26 18.04
Volume** 0.63 ± 0.3 (0.1– 1.5) 0.6 0.8
Ph 6.86 ± 0.45 (6.27 – 7.8) 6.83 7.17 ±
Potassium* 19.66± 3.25 (10.8 – 24.8) 19.55 16.82
Sodium* 19.90 ± 9.3 (8 – 48) 17.5 12.26
Bicarbonate* 5.53 ± 3.98 (0 – 22) 3 3.58
CF – Cystic Fibrosis, CI – Confidential interval, n – number of patients, SD – Standar
* mmol/L.
** N for volume is 68 in CF patients and 64 in healthy subjects, unlike the other pa
*** The Statistical analyses were performed by Mann-Whitney test. The positive p-vThe collection method for saliva is simple and nonin-
vasive and the donation process is associated with
minimal stress allowing multiple collections to be per-
formed. Oral fluid sampling is safe for both the oper-
ator and patient, and involves easy and low-cost storage
[7,8]. Particularly in the case of CF, the use of saliva as
a diagnostic test could bring benefits, considering that
saliva is easier to collect than sweat [9].
In this context, studies on the effects of CF on the
functioning of salivary glands have produced conflicting
results. Also, the parameters considered, measurement
methods used and conditions applied in the obtainment
of saliva differ, as shown in Table 1, making it difficult to
compare the results.
In this context, the aim of this study was to compare
the pH, volume of saliva and concentrations of bicar-
bonate, sodium, chloride, potassium, glucose, lactate and
calcium in saliva samples taken from CF patients and
healthy subjects, with a view to providing an alternative
tool for CF diagnosis.Methods
An analytical observational study (case–control) was
carried out for which individuals with or without the
disease (cystic fibrosis) were selected. The case group
(n = 80) was comprised of patients with CF at the
Unicamp Teaching Hospital and the control group
(n = 84) was comprised of healthy individuals recruited
from a school (from 04 to 18 years old) and a university.
The characterization according to age for both groups is
shown in Table 2.
The subjects of the control group were all from the same







± SD (95% CI) Median
2.79 (0.71 – 23) 1.61 0.114 1
3.56 (3 – 20) 9.5 0.932 1
0.74 (0.1 – 4.3) 0.6 0.463 1
± 8.3 (8 – 43) 16 <0.001 <0.009
± 0.5 (0 – 2) 1 <0.001 <0.009
0,44 (6.3 – 7.85) 7.2 <0.001 <0.009
± 3.22 (6.5 -24) 17.20 <0.001 <0.009
± 4.31 (7 – 29) 11 <0.001 <0.009
± 3.98 (0 -16) 1.95 0.051 0.459
d Deviation.
rameters.
alue is in bold.
Table 2 Sample characterization according to age (years)
Parameter CF group Control group
No. of Patients 80 84
Mean 12.38 18.2
Median 12.0 17.0
Std. Deviation 7.1 5.24
Minimum 4.0 5.0
Maximum 34.0 28.0
CF – Cystic Fibrosis. There was no statistically significant difference
between groups.
The statistical analysis was performed applying the Mann–Whitney test. The
positive p-value is in bold.
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http://www.diagnosticpathology.org/content/8/1/46continuous use and did not take any medicine during the
saliva collection period.
In the case of the CF patients the diagnosis was carried
out considering two chloride concentrations in sweat
greater than or equal to 60 mEq/L and/or in the genetic
study positive results for two CFTR gene mutations.
The saliva collection was performed after rinsing of
the mouth with water for one minute to eliminate con-
tamination and stimulate the salivary glands. The collec-
tion took place at the same time of the day (afternoon)
for both the case group and control group to avoid pos-
sible physiological interferences.
The saliva samples were collected with a cotton swab -
SalivetW (Sardest-Germany - http://www.sarstedt.com)
by chewing sterile cotton rolls for one minute. The sam-
ples were immediately centrifuged at 1800 rpm for 15
minutes after the collection and the saliva volume was
measured.
Bicarbonate, pH, sodium, chloride, potassium, glucose,
calcium and lactate concentrations were determined on
an ABL gasometer (model 835, RadiometerW, Denmark)
using 20 μL of saliva by gasometric analysis using an
ion-selective electrode (http://www.radiometer.com).
The project was approved by the University Ethics
Committee (#157/2010) and all patients and/or their
guardians gave their informed consent.
Statistical analysis
The calculation of the sample size using the program
GPowerW, version 3.1.2 [10] applying the Mann–Whitney
Test, indicated that 67 individuals were needed for each
group, considering a sample power of 80% and α = 0.05.
The sample power was previously calculated by the statis-
tics sector of the university.
The Mann–Whitney test was used to evaluate the differ-
ence between the results for the biochemical parameters
obtained for the two groups (CF patients and healthy sub-
jects), with a 5% significance level. The Receiver Operating
Characteristic (ROC) curve was constructed to measure
the sensitivity and specificity of chloride and sodium se-
cretion as a tool for CF diagnosis.The Statistical Package for the Social SciencesW ver-
sion 17 (SPSS) was used for the statistical analysis [11].
To avoid spurious data caused by the performance of
multiple tests [12], the significance level (α) was adjusted
using the Bonferroni correction method (α corrected =
0.05/number of tests).
Results
The study comprised 164 subjects (46.99% male and
53.01% female), with a mean age of 13.3 years (±6.65).
The mean age of the CF patients (n = 80) was 13.04
years (±7.27) and that of the healthy subjects (n = 84)
was 13.56 years (±6.03 years). There was no statistically
significant difference between the mean ages of the CF
patients and healthy subjects (p = 0.297).
The saliva markers and their distribution among groups
(CF patients and healthy subjects) can be seen in Table 1.
The chloride, potassium and sodium concentrations were
higher in CF patients when compared with health sub-
jects. The volume and pH of the saliva were lower for CF
patients when compared with healthy subjects. In Figure 1,
a box plot shows the sodium and chloride concentrations
in the saliva (p < 0.009).
The ROC curve compared the healthy subjects versus
CF patients and the values for sodium were: cutoff: 13.5
mmol/L, sensitivity: 73.4%, specificity: 70.6%; and for
chloride: cutoff: 20mmol/L, sensitivity: 68.1%, specificity:
72.9% (Figure 2).
Discussion
The saliva composition can be affected by some diseases
and thus can be used as a diagnostic tool [21]. In CF, the
ion concentrations (sodium and chloride) in the sweat
and saliva are altered. Although, the sweat test is a ‘gold
standard’ tool to CF diagnosis, several problems are as-
sociated with this examination, such as: (i) lack of equip-
ment, (ii) high cost, (iii) lack of professional specialists,
(iv) difficult collection, (v) processing for chloride and
sodium determination is not carried out at the same
time or with the same method. In this context, there is a
need for an alternative tool for CF diagnosis.
Results obtained in previous studies have indicated
that assessment of the salivary profile, particularly of
sodium and chloride concentrations, is important, sug-
gesting that this approach could be used as a tool for CF
diagnosis [21]. The results reported in the literature are
difficult to compare for the following reasons: (i)
methods used for the saliva collection and ion concen-
tration determination differ; (ii) different patient inclu-
sion criteria are applied; and (iii) the study populations
are small. In this context, this study involved a larger
population in comparison with others, and a new tech-
nique was used to determine the ion concentrations. It
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Figure 1 Box plot of levels of sodium and chloride. A. Comparison of sodium concentrations in saliva of healthy subjects and CF patients,
* p < 0.009. B. Comparison of chloride concentrations in saliva of healthy subjects and CF patients, * p < 0.009.
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http://www.diagnosticpathology.org/content/8/1/46equipment for blood gas analysis and the assessment of
saliva biochemical markers.
Only eight studies on the biochemical parameters of
saliva collected from CF patients could be found in the
literature, involving different saliva sampling and ion
concentration measurement methods, as shown in
Table 3. Since 1996 no studies on saliva as a diagnostic
tool for CF have been carried out. In three studies,
atomic absorption spectrometry was used to measure
the biochemical parameters. In one of these Jimenez-
Reyes and Sanchez-Aguirre [20] evaluated the levels of
chloride and sodium in the saliva of nine patients withCF and nine control subjects, and found differences be-
tween the groups, with an increase in the concentration
of sodium in the CF group, as we observed in the study
reported herein. In a study by Blomfield et al. [18],
atomic absorption spectrometry was also used for the
saliva assessment. After using 10% citric acid to stimu-
late saliva production in 63 individuals (35 with CF), the
authors observed statistically significant differences in
the values for both chloride and sodium on comparing
the results for the two groups, as also reported herein.
In another study, Wiesmann et al. [16] did not find sta-
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Figure 2 ROC curves for chloride and sodium. A. ROC curve for
chloride concentration. Cutoff: 13.5mmol/l, sensitivity: 73.4%,
specificity: 70.6%; B. ROC curve for sodium concentration. Cutoff:
20mmol/l, sensitivity: 68.1%, specificity: 72.9%.
Table 3 Literature data on sodium and chloride concentration
Researchers Date CFG° CG* Method
Chernick et al. [13] 1961 12 12 Flame photometry/titrati
Marmar et al. [14] 1966 12 13 Flame photometry/titrati
Lawson et al. [15] 1967 5 50 Electrode selective
Wiesmann et al. [16] 1970 23 12 Atomic absorption
spectrophotometry
Fritz et al. [17] 1972 11 0 Unquoted
Blomfield et al. [18] 1973 35 28 Atomic absorption
spectrophotometry
Kollberg et al. [19] 1982 9 11 Flame-emission photom
Jimenez-Reyes & Sanches-
Aguirre [20]
1996 9 9 Atomic absorption
spectrophotometry
°CFG: cystic fibrosis group; *CG: control group. Databases of Pubmed, Scielo, Medlin
searched. The keywords were: biochemical parameters of saliva and cystic fibrosis.
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http://www.diagnosticpathology.org/content/8/1/46the CF and control groups. Although the patients in-
volved in these studies had ages similar to those of our
study reported herein, the different technique used does
not allow reliable comparison with our results.
Also, in agreement with our observations, in studies
carried out by Marmar et al. [14] and Blomfield et al.
[18] the chloride concentration in the saliva was high for
CF patients in comparison with healthy subjects.
Chernick et al. [13] evaluated the saliva of 24 subjects
divided into two groups: CF patients (n = 12) and healthy
subjects (n = 12). The levels of sodium and potassium
were analyzed by the flame-photometry technique and
the chloride concentration by titration. The CF patients
had lower levels of sodium and chloride, in contrast to
the results obtained in our study. However, the potas-
sium level in the CF group was higher than that of the
control group, as we also found in our study.
It is noteworthy that in the present study no chemical
was used to stimulate salivary flow, in contrast with
most other studies on salivary parameters in CF patients.
This procedure may alter the volume, pH and biochem-
ical parameters of saliva. According to Catalán et al. [6],
studies conducted to evaluate the effect of CF on the
functioning of the salivary glands have produced con-
flicting results. Blomfield et al. [18,22] demonstrated that
CF had no influence on the salivary flow of the patients.
Marmar et al. [14], on evaluating 12 patients with CF
and 13 healthy children, found that the volume of saliva
was higher in CF patients at all times after salivary
stimulation. However, in our study, we found that the
salivary flow is decreased in the CF group, consistent
with the findings of other studies cited herein [23,24].
Kollberg et al. [19] evaluated nine patients with CF and
11 control subjects and observed reduced salivary flow
in CF patients. Ceder et al. [23] evaluated 12 patients,
aged 8–16 years, before and after stimulation with 2%s in saliva of patients with cystic fibrosis (CF)
Results
on High level of potassium and low levels of sodium and chloride in
patients with CF
on High levels of sodium and chloride in CF patients
High level of sodium in CF patients
No significant differences in sodium level
High levels of chloride and sodium for saliva flow in CF patients
High levels of chloride and sodium in CF patients
etry High level of sodium in CF patients
High level of sodium in CF patients
e and HighWire Stanford University, in the period of 1951 to 2011 were
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http://www.diagnosticpathology.org/content/8/1/46citric acid. The authors observed a reduction in the sal-
ivary flow of CF patients when compared with the con-
trol group, both before and after salivary stimulation. In
these studies, the authors concluded that the results
suggest a primary defect related to the disease or a sec-
ondary defect due to the destruction of the glandular
parenchyma. Pedersen et al. [24], in a review of sali-
vary functions, cited several causes in relation to hypo-
salivation including medications, autoimmune disease,
endocrine disorders, genetic disorders (including CF),
malnutrition and infection. Previous studies showed
conflicting results regarding the changes in salivary flow
in CF, but in these studies the number of subjects was
too small to draw decisive conclusions on the subject,
while the results reported herein suggest a more consist-
ent finding of hyposalivation.
In this study, the mean pH of the saliva of the CF pa-
tients was lower than that of the healthy subjects. In this
regard, we could not find another study considering the
pH of saliva collected from CF patients in the literature.
Although the results obtained suggest that saliva com-
position is a possible tool for CF diagnosis, further stud-
ies need to be carried out to evaluate this hypothesis,
given that the methods for assessing salivary parameters
differ, which hinders comparisons. In relation to the lim-
itations of this study, the difficulty associated with
obtaining voluntary saliva from children under 7 years
old should be highlighted. However, as previously men-
tioned, it is worth noting that saliva collection is a safe,
noninvasive, simple and inexpensive method, which does
not require dermal puncture and can be collected re-
peatedly without discomfort [25]. Thus, the evaluation
of salivary composition may lead to the establishment of
an alternative to the sweat test in the future, which is
easier to conduct and more effective. Some biochemical
parameters of saliva, such as potassium, chloride, so-
dium, pH and volume appear to be influenced by CF.
Further studies are needed to confirm the usefulness of
the evaluation of salivary parameters as a complemen-
tary method for diagnosing this disease.
Conclusions
The results of this study indicated that saliva cannot be
used as a diagnosis tool for CF. Nevertheless, with the
application of other methods to identify the ion concen-
tration of saliva, in studies based on a sufficiently large
population, and by performing the comparison consider-
ing the saliva and sweat tests at the same time, new in-
sights could be gained regarding the use of saliva as an
important CF diagnosis tool.
Abbreviations
CF: Cystic Fibrosis; CFTR: Cystic fibrosis transmembrane conductance
regulator; ENaC: Epithelial Na + channel; Rpm: Revolutions per minute;
ROC: Receiver Operating Characteristic.Competing interests
The authors declare that they have no competing interests.Authors' contributions
ACG/CEL: Responsible for collecting and analyzing samples, inputting test
results, data analysis, comparison of results with others published in the
literature, publication of results and writing of the article. RMHM/IAP/FALM/
AFR/JDR: Collaboration in data analysis, comparison of results with others
published in the literature, publication of results and writing of the article. All
authors read and approved the final manuscript.Acknowledgements
We thank all of the staff at the gasometric laboratory of the division of
clinical pathology, at the Unicamp Teaching Hospital, who contributed to
the completion of this survey and particularly the patients at the Unicamp
Teaching Hospital and healthy subjects who participated in the study.
Author details
1Department of Pediatrics, Faculty of Medical Sciences, University of
Campinas, P.O. Box: 6111, Campinas, SP 13081-970, Brazil. 2Department of
Genetics, Faculty of Medical Sciences, University of Campinas, P.O. Box: 6111,
Campinas, SP 13081-970, Brazil. 3Department of Clinical Pathology, Faculty of
Medical Sciences, University of Campinas, P.O. Box: 6111, Campinas, SP
13081-970, Brazil. 4Boldrini Children's Center, Campinas, Brazil. 5Department
of Medical Clinics, Faculty of Medical Sciences, University of Campinas,
P.O. Box: 6111, Campinas, SP 13081-970, Brazil. 6Department of Clinical
Pathology, Alexander Fleming Street 105, FCM12, Second floor, Barão
Geraldo, Campinas, SP 13083-881, Brazil.
Received: 19 December 2012 Accepted: 10 March 2013
Published: 19 March 2013References
1. Strausbaugh SD, Davis PB: Cystic fibrosis: a review of epidemiology and
pathobiology. Clin Chest Med 2007, 28(2):279–288.
2. Di Sant'SAgnese PA, Darling RC, Perara GA, Shea E: Abnormal electrolyte
composition of sweat in cystic fibrosis of the pancreas. Am J Dis Child
1953, 86(5):618–619.
3. Gibson LE, Cooke RE: A test for concentration of electrolytes in sweat in
cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.
Pediatrics 1959, 23(3):545–549.
4. Mishra A, Greaves R, Massie J: The limitations of sweat electrolyte
reference intervals for the diagnosis of cystic fibrosis: a systematic
review. Clin Biochem Rev 2007, 28(2):60–76.
5. Ledford H: Drugs best’s cystic fibrosis mutation. Nature 2012, 482(7384):145.
6. Catalán MA, Nakamoto T, Gonzalez-Begne M, Camden JM, Wall SM, Clarke
LL, Melvin JE: CFTR and ENaC ion channels mediate NaCl absorption in
the mouse submandibular gland. J Physiol 2010, 588(Pt 4):713–724.
7. Greabu M, Battino M, Mohora M, Totan A, Didilescu A, Spinu T, Totan C,
Miricescu D, Radulescu R: Saliva-a diagnostic window to the body, both in
health and in disease. J Med Life 2009, 2(2):124–132.
8. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C: Diagnostic
potential of saliva: current state and future applications. Clin Chem 2011,
57(5):675–687.
9. Chiappin S, Antonelli G, Gatti R, De Palo EF: Saliva specimen: A new
laboratory tool for diagnostic and basic investigation. Clin Chim Acta
2007, 383(1–2):30–40.
10. Faul F, Erdfelde E, Lang AG, Buchner A: G*Power 3: A flexible sta-tistical
power analysis program for the social, behavioral, and biomedical
sciences. Behav Res Methods 2007, 39:175–191.
11. SPSS 17.0 for Windows (computer program). Statistical Package for Social
Science (SPSS). Release Version 17.0.1. Chicago (IL): SPSS. Incorporation; 2011.
Available from: http:// www.spss.com.
12. Drăghici S: Data analysis tools for DNA microarrays. New York: Chapman &
Hall/CRC; 2003.
13. Chernick WS, Barbero GJ, Parkins FM: Studies on submaxillary saliva in
cystic fibrosis. J Pediatr 1961, 59(6):890–898.
14. Marmar J, Barbero GJ, Sibinga MS: The pattern of parotid gland secretion
in cystic fibrosis of the pancreas. Gastroenterology 1966, 50(4):551–556.
Gonçalves et al. Diagnostic Pathology 2013, 8:46 Page 7 of 7
http://www.diagnosticpathology.org/content/8/1/4615. Lawson D, Saggers BA, Chapman MJ: Screening for Cystic Fibrosis by
measurement of Unstimulated Parotid Saliva Sodium Levels. Arch Dis
Childh 1967, 42(226):689–690.
16. Wiesmann UN, Boat TF, di Sant'Agnese PA: Sodium concentration in
unstimulated parotid saliva and on oral mucosa in normal subjects and
in patients with cystic fibrosis. J Pediatr 1970, 76(3):444–448.
17. Fritz ME, Caplan DB, Leever D, Levitt J: Composition of parotid saliva on
different days in patients with cystic fibrosis. Am J Dis Child 1972,
123(2):116–117.
18. Blomfield J, Warton KL, Brown JM: Flow rate and inorganic components of
submandibular saliva in cystic fibrosis. Arch Dis Child 1973, 48(4):267–274.
19. Kollberg H, Danielsson A, Glitterstam K, Henriksson R, Marklund S: Studies
on parotid saliva in cystic fibrosis. Acta Paediatr Scand 1982, 71(2):321–322.
20. Jimenez-Reyes M, Sanchez-Aguirre JF: Sodium and chloride concentrations
in mixed saliva. Appl Radiat Isot 1996, 47(3):273–277.
21. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C: Diagnostic
Potential of Saliva: Current State and Future Applications.
Clinical Chemistry 2011, 57(5):675–687.
22. Blomfield J, Rush AR, Allars HM, Brown JM: Parotid gland function in
children with cystic fibrosis and child control subjects. Pediatr Res 1976,
10(6):574–578.
23. Ceder O, Van Dijken J, Ericson T, Kollberg H: Ribonuclease in different
types of saliva from cystic fibrosis patients. Acta Paediatr Scand 1985,
74(1):102–106.
24. Pedersen AM, Bardow A, Jensen SB, Nauntofte B: Saliva and
gastrointestinal functions of taste, mastication, swallowing and
digestion. Oral Dis 2002, 8(3):117–129.
25. Mandel ID: The diagnostic uses of saliva. J Oral Pathol Med 1990,
19(3):119–125.
doi:10.1186/1746-1596-8-46
Cite this article as: Gonçalves et al.: Saliva as a potential tool for cystic
fibrosis diagnosis. Diagnostic Pathology 2013 8:46.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
